Education
About Us
Working with TipRanks
Follow Us
THC Biomed (THCBF)
:THCBF
Total Valuation
THC Biomed INTL has a market cap or net worth of $2.39M. The enterprise value is $0.00.
Market Cap$2.39M
Enterprise Value$0.00
Share Statistics
THC Biomed INTL has 163,937,870 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding163,937,870
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
THC Biomed INTL’s return on equity (ROE) is 0.00 and return on invested capital (ROIC) is 0.00%.
Return on Equity (ROE)0.00
Return on Assets (ROA)0.00
Return on Invested Capital (ROIC)0.00%
Return on Capital Employed (ROCE)0.00
Revenue Per Employee0.00
Profits Per Employee0.00
Employee Count35
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of THC Biomed INTL is 0.00. THC Biomed INTL’s PEG ratio is 0.00.
PE Ratio0.00
PS Ratio0.00
PB Ratio0.00
Price to Fair Value0.00
Price to FCF0.00
Price to Operating Cash Flow0.00
PEG Ratio0.00
Income Statement
In the last 12 months, THC Biomed INTL had revenue of 0.00 and earned 0.00 in profits. Earnings per share was 0.00.
Revenue0.00
Gross Profit0.00
Operating Income0.00
Pretax Income0.00
Net Income0.00
EBITDA0.00
Earnings Per Share (EPS)0.00
Cash Flow
In the last 12 months, operating cash flow was 38.91K and capital expenditures -71.49K, giving a free cash flow of -69.91K billion.
Operating Cash Flow38.91K
Free Cash Flow-69.91K
Free Cash Flow per Share>-0.01
Dividends & Yields
THC Biomed INTL pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-424.86
52-Week Price Change100.00%
50-Day Moving Average0.02
200-Day Moving Average―
Relative Strength Index (RSI)53.97
Average Volume (3m)0.00
Important Dates
THC Biomed INTL upcoming earnings date is Jun 27, 2024, TBA Not Confirmed.
Last Earnings DateMar 29, 2024
Next Earnings DateJun 27, 2024
Ex-Dividend Date―
Financial Position
THC Biomed INTL as a current ratio of 0.00, with Debt / Equity ratio of 0.00%
Current Ratio0.00
Quick Ratio0.00
Debt to Market Cap0.00
Net Debt to EBITDA0.00
Interest Coverage Ratio0.00
Taxes
In the past 12 months, THC Biomed INTL has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
THC Biomed INTL EV to EBITDA ratio is 0.00, with an EV/FCF ratio of 0.00.
EV to Sales0.00
EV to EBITDA0.00
EV to Free Cash Flow0.00
EV to Operating Cash Flow0.00
Balance Sheet
THC Biomed INTL has $0.00 in cash and marketable securities with C$0.00 in debt, giving a net cash position of $0.00 billion.
Cash & Marketable Securities$0.00
Total DebtC$0.00
Net Cash$0.00
Net Cash Per Share$0.00
Tangible Book Value Per Share$0.00
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for THC Biomed INTL is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―